Nankai Chemical Company,Limited (TYO:4040)
Japan · Delayed Price · Currency is JPY 3,860.00
-40.00 (-1.03%)
Aug 27, 2026, 3:30 PM JST
TYO:4040 Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 21,183 | 21,063 | 20,900 | 19,987 | 19,601 | 17,434 | |
Revenue Growth | 0.56% | 0.78% | 4.57% | 1.97% | 12.43% | 5.90% |
Cost of Revenue | 14,976 | 15,083 | 15,388 | 14,482 | 15,096 | 13,306 |
Gross Profit | 6,207 | 5,980 | 5,512 | 5,505 | 4,505 | 4,128 |
Selling, General & Admin | 4,228 | 4,280 | 4,206 | 3,940 | 3,708 | 3,388 |
Operating Expenses | 4,228 | 4,280 | 4,206 | 3,940 | 3,708 | 3,388 |
Operating Income | 1,979 | 1,700 | 1,306 | 1,565 | 797 | 740 |
Interest Expense | -54 | -60 | -65 | -43 | -42 | -46 |
Interest & Investment Income | 13 | 18 | 29 | 23 | 14 | 10 |
Earnings From Equity Investments | 15 | 9 | 18 | 28 | 30 | -30 |
Currency Exchange Gain (Loss) | 11 | - | - | - | 30 | 35 |
Other Non Operating Income (Expenses) | 105 | 91 | 167 | 207 | 30 | 6 |
EBT Excluding Unusual Items | 2,069 | 1,758 | 1,455 | 1,780 | 859 | 715 |
Gain (Loss) on Sale of Investments | - | - | 11 | 76 | - | - |
Gain (Loss) on Sale of Assets | 2,545 | 2,519 | 15 | - | 30 | 529 |
Asset Writedown | -188 | -183 | -193 | -194 | -154 | -333 |
Other Unusual Items | -9 | -10 | 58 | -1 | -72 | -448 |
Pretax Income | 4,417 | 4,084 | 1,346 | 1,661 | 663 | 463 |
Income Tax Expense | 1,370 | 1,283 | 296 | 484 | 153 | -9 |
Earnings From Continuing Operations | 3,047 | 2,801 | 1,050 | 1,177 | 510 | 472 |
Net Income to Company | - | 2,801 | 1,050 | 1,177 | 510 | 472 |
Minority Interest in Earnings | -24 | -25 | -35 | -19 | -6 | -10 |
Net Income | 3,023 | 2,776 | 1,015 | 1,158 | 504 | 462 |
Net Income to Common | 3,023 | 2,776 | 1,015 | 1,158 | 504 | 462 |
Net Income Growth | 240.43% | 173.50% | -12.35% | 129.76% | 9.09% | 198.06% |
Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 1 | 1 |
Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 1 | 1 |
Shares Change | 0.37% | 0.63% | 0.27% | 56.67% | - | 21.31% |
EPS (Basic) | 1500.87 | 1375.09 | 505.55 | 586.41 | 391.90 | 359.24 |
EPS (Diluted) | 1490.34 | 1365.91 | 502.64 | 575.01 | 391.90 | 359.24 |
EPS Growth | 239.10% | 171.75% | -12.59% | 46.72% | 9.09% | 145.70% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -1,515 | -1,854 | 587 | 152 | - |
Free Cash Flow Per Share | - | -745.19 | -917.69 | 291.33 | 118.19 | - |
Dividend Per Share | 60.000 | 60.000 | 55.000 | 50.000 | 15.000 | 15.000 |
Dividend Growth | 9.09% | 9.09% | 10.00% | 233.33% | 0% | - |
Gross Margin | 29.30% | 28.39% | 26.37% | 27.54% | 22.98% | 23.68% |
Operating Margin | 9.34% | 8.07% | 6.25% | 7.83% | 4.07% | 4.25% |
Profit Margin | 14.27% | 13.18% | 4.86% | 5.79% | 2.57% | 2.65% |
Free Cash Flow Margin | - | -7.19% | -8.87% | 2.94% | 0.78% | - |
EBITDA | 3,216 | 2,917 | 2,442 | 2,587 | 1,802 | - |
EBITDA Margin | 15.18% | 13.85% | 11.68% | 12.94% | 9.19% | - |
D&A For EBITDA | 1,237 | 1,217 | 1,136 | 1,022 | 1,005 | - |
EBIT | 1,979 | 1,700 | 1,306 | 1,565 | 797 | 740 |
EBIT Margin | 9.34% | 8.07% | 6.25% | 7.83% | 4.07% | 4.25% |
Effective Tax Rate | 31.02% | 31.41% | 21.99% | 29.14% | 23.08% | - |